Skip to content
2000
Volume 2, Issue 1
  • ISSN: 1872-3128
  • E-ISSN: 1874-0758

Abstract

The new analgesic tapentadol was evaluated for induction and inhibition of several cytochrome P450 enzymes in vitro, and protein binding was assessed. It was concluded that no clinically relevant drug-drug interactions are likely to occur through either mechanism.

Loading

Article metrics loading...

/content/journals/dml/10.2174/187231208783478434
2008-01-01
2025-11-01
Loading full text...

Full text loading...

/content/journals/dml/10.2174/187231208783478434
Loading

  • Article Type:
    Research Article
Keyword(s): CYP isoforms; glucuronidation; Hepatocytes; omeprazole; protein binding
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test